These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 23088652)
21. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Pattison DI; Hawkins CL; Davies MJ Chem Res Toxicol; 2009 May; 22(5):807-17. PubMed ID: 19326902 [TBL] [Abstract][Full Text] [Related]
23. Hypothiocyanous acid reactivity with low-molecular-mass and protein thiols: absolute rate constants and assessment of biological relevance. Skaff O; Pattison DI; Davies MJ Biochem J; 2009 Jul; 422(1):111-7. PubMed ID: 19492988 [TBL] [Abstract][Full Text] [Related]
24. Role of thiocyanate in the modulation of myeloperoxidase-derived oxidant induced damage to macrophages. Guo C; Davies MJ; Hawkins CL Redox Biol; 2020 Sep; 36():101666. PubMed ID: 32781424 [TBL] [Abstract][Full Text] [Related]
25. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. Shao B Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192 [TBL] [Abstract][Full Text] [Related]
26. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ J Lipid Res; 1999 Feb; 40(2):345-53. PubMed ID: 9925665 [TBL] [Abstract][Full Text] [Related]
27. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein. Lu N; Xie S; Li J; Tian R; Peng YY Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002 [TBL] [Abstract][Full Text] [Related]
28. Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F. White CR; Datta G; Buck AK; Chaddha M; Reddy G; Wilson L; Palgunachari MN; Abbasi M; Anantharamaiah GM J Lipid Res; 2012 Aug; 53(8):1576-87. PubMed ID: 22589558 [TBL] [Abstract][Full Text] [Related]
29. Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages. Bergt C; Reicher H; Malle E; Sattler W FEBS Lett; 1999 Jun; 452(3):295-300. PubMed ID: 10386609 [TBL] [Abstract][Full Text] [Related]
30. A pivotal role for NF-κB in the macrophage inflammatory response to the myeloperoxidase oxidant hypothiocyanous acid. Pan GJ; Rayner BS; Zhang Y; van Reyk DM; Hawkins CL Arch Biochem Biophys; 2018 Mar; 642():23-30. PubMed ID: 29410057 [TBL] [Abstract][Full Text] [Related]
31. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Hazell LJ; Davies MJ; Stocker R Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584 [TBL] [Abstract][Full Text] [Related]
32. The therapeutic potential of thiocyanate and hypothiocyanous acid against pulmonary infections. Ashtiwi NM; Kim SO; Chandler JD; Rada B Free Radic Biol Med; 2024 Jul; 219():104-111. PubMed ID: 38608822 [TBL] [Abstract][Full Text] [Related]
33. Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins Yan Y; Lu S; Jia S; Dong Q; Wang L; Wang Y Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023964 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of recombinant high density lipoprotein with apolipoprotein A-I and apolipoprotein A-V. Zhang X; Chen B Biol Chem; 2011 May; 392(5):423-9. PubMed ID: 21476871 [TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690 [TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437 [TBL] [Abstract][Full Text] [Related]
37. A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins. Park KH; Cho KH Fish Shellfish Immunol; 2011 Dec; 31(6):904-10. PubMed ID: 21906681 [TBL] [Abstract][Full Text] [Related]
38. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein. Jin Z; Zhou L; Tian R; Lu N Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588 [TBL] [Abstract][Full Text] [Related]
39. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387 [TBL] [Abstract][Full Text] [Related]
40. Plasma phospholipid transfer protein-mediated reactions are impaired by hypochlorite-modification of high density lipoprotein. Pussinen PJ; Metso J; Keva R; Hirschmugl B; Sattler W; Jauhiainen M; Malle E Int J Biochem Cell Biol; 2003 Feb; 35(2):192-202. PubMed ID: 12479869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]